Evidence map›Paper›PMID 40495300›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2025

Xpert MTB/RIF Ultra 'trace': considerations for diagnostics.

L E Scott, M P da Silva, P Marokane, H E Jenkins, W S Stevens

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Closing gaps through innovation in the tuberculosis pathology value chain.Journal of clinical tuberculosis and other mycobacterial diseases · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

L E ScottWits Diagnostic Innovation Hub, Faculty of Health Science, University of the Witwatersrand, Johannesburg, South Africa.
M P da SilvaWits Diagnostic Innovation Hub, Faculty of Health Science, University of the Witwatersrand, Johannesburg, South Africa;, National Priority Program of the National Health Laboratory Service, Johannesburg, South Africa.
P MarokaneNational Priority Program of the National Health Laboratory Service, Johannesburg, South Africa.
H E JenkinsDepartment of Biostatistics, Boston University School of Public Health, Boston, MA 02118, USA.
W S StevensWits Diagnostic Innovation Hub, Faculty of Health Science, University of the Witwatersrand, Johannesburg, South Africa;, National Priority Program of the National Health Laboratory Service, Johannesburg, South Africa.

Funding

Evaluating the tuberculosis epidemic in South Africa using a novel ten-year cohortR01AI152126 · NIAID · WITS HEALTH CONSORTIUM (PTY), LTD · PI JENKINS, HELEN E., SCOTT, LESLEY · 2020 to 2024
$1.6M
NIAID NIH HHS R01 AI152126
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40495300
PMCPMC12951405

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.